An Updated Review of Lysophosphatidylcholine Metabolism in Human Diseases

Lysophosphatidylcholine (LPC) is increasingly recognized as a key marker/factor positively associated with cardiovascular and neurodegenerative diseases. However, findings from recent clinical lipidomic studies of LPC have been controversial. A key issue is the complexity of the enzymatic cascade in...

Descripción completa

Detalles Bibliográficos
Autores principales: Law, Shi-Hui, Chan, Mei-Lin, Marathe, Gopal K., Parveen, Farzana, Chen, Chu-Huang, Ke, Liang-Yin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429061/
https://www.ncbi.nlm.nih.gov/pubmed/30845751
http://dx.doi.org/10.3390/ijms20051149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429061/
https://www.ncbi.nlm.nih.gov/pubmed/30845751
http://dx.doi.org/10.3390/ijms20051149

Ejemplares similares